Around 27% of people diagnosed with atrial fibrillation (AFib) experience no symptoms, and an estimated 2 million Americans may unknowingly live with this condition. (1, 2) Often called a "silent" ...

How wearables are reshaping chronic disease management with real-time data, personalized treatment, and early intervention ...

Whoop expands its wearable journey with the launch of two updated fitness trackers — the Whoop 5.0 and the Whoop MG — both unveiled on May 8. Both devices are designed to deli ...

In particular, ICMs may have an emerging role in the management of patients with atrial fibrillation and in those ... store a one-lead ECG tracing, both retrospectively and prospectively, for ...

Upon review of this body and the described ECG findings, certain common patterns ... studies (most commonly nonsustained SVT, atrial fibrillation and sinus bradycardia). Including studies on ...

Tempted to skip the floss? Your heart might thank you if you don't. A new study from Hiroshima University (HU) finds that the ...

It’s not as “perfect as they are selling it,” but it does avoid the more catastrophic complications of thermal ablation, says ...

This week brings the launch of a new pair of Anker earbuds, the long-awaited debut of the latest Roborock robotic vacuum and ...

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...